オプションチェーンは、Lifeway Foodsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Lifeway Foodsの市場センチメントを評価します。.

Lifeway Foods (NASDAQ:LWAY) 株価情報, オプションチェーン

Lifeway Foods

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

Lifeway Foods Inc

As of April 3, 2025, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Dole PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOLE#NYSE">DOLE</a>)</h3>
<ul>
<li>On Feb. 26, Dole posted better-than-expected fourth-quarter financial results. The company's stock gained around 5% over the past five days and has a 52-week high of $17.12.</li>
<li>RSI Value: 71.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>DOLE Price Action: Shares of Dole gained 1.1% to close at $14.66 on Wednesday.</li>
<li>Edge Stock Ratings: 75.90 Momentum score with Value at 85.83. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/dole"><img loading="lazy" decoding="async" width="441" height="177" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7.png" alt="" class="wp-image-854816" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7-300x120.png 300w" sizes="(max-width: 441px) 100vw, 441px" /></a></figure>
<h3 class="wp-block-heading">Adecoagro SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>)</h3>
<ul>
<li>On March 27, Adecoagro announced a deal with Tether Investments, under which Tether will launch a tender offer to acquire a majority stake in the South American agribusiness at $12.41 per share. Adecoagro CEO and Co-Founder Mariano Bosch said, "I am very excited about this transaction and the opportunity to have a significant shareholder like Tether, who shares the entrepreneurial spirit that led us to create Adecoagro 23 years ago and that continues to be present in our day-to-day decisions." The company's stock gained around 5% over the past month and <a href="https://www.benzinga.com/quote/AGRO">has a 52-week high</a> of $12.08.</li>
<li>RSI Value: 73.5</li>
<li>AGRO Price Action: Shares of Adecoagro gained 0.1% to close at $11.36 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Lifeway Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>)</h3>
<ul>
<li>On March 14, Lifeway Foods posted weaker-than-expected quarterly results. &#8220;I am pleased to report another record year of net sales for Lifeway, spearheaded by the continued, strong volume growth of our flagship drinkable Lifeway Kefir,&#8221; commented Julie Smolyansky, President and Chief Executive Officer of Lifeway. The company's stock gained around 19% over the past month and has a <a href="https://www.benzinga.com/quote/LWAY">52-week high</a> of $28.61.</li>
<li>RSI Value: 74.6</li>
<li>LWAY Price Action: Shares of Lifeway Foods gained 0.6% to close at $24.84 on Wednesday.</li>
</ul>
Learn more about BZ Edge Rankings—click to see scores for other <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">stocks in the sector and see how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

AGRO

DOLE

LWAY

Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs

Lifeway notes that Edward Smolyansky was previously terminated for cause as an officer of the company.
Lifeway said Audit and Corporate Governance Committee will review Mr. Smolyansky's nominees, and the Board will make a recommendation in due course. &nbsp;

Lifeway Foods Issues Response Regarding Edward Smolyansky's Nomination Notice With Respect To Seven Candidates To Board; Asks Shareholders Not To Take Any Action At This Time

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.21 by 104.76 percent. This is a 103.85 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $46.93 million which missed the analyst consensus estimate of $48.00 million by 2.22 percent. This is a 11.50 percent increase over sales of $42.09 million the same period last year.

Earnings

Lifeway Foods Q4 EPS $(0.01) Misses $0.21 Estimate, Sales $46.93M Miss $48.00M Estimate

Reported Earlier, Lifeway Farmer Cheese Grows Retail Presence With Rollout To 1,400 Albertsons Locations

Lifeway was an early investor in Simple Foods in 2015 and since that time, the Company has already realized a $1.5 million gain in 2019, bringing the total expected net proceeds to Lifeway of approximately $6.5 million.

Lifeway Foods Expects To Realize Approximately $5M Of Net Profit Due To Recently Announced Sale Of Simple Foods To Flowers Foods

Edward Smolyansky said, "Lifeway seems determined to plunge the Company deeper and deeper into litigation this time via proxy by Julie. We look forward to providing all shareholders a fully transparent accounting of the inner workings of America's Worst Governed Publicly Traded Company."
Ludmila Smolyansky stated, "After they cut a check to Julie for $2 million, I anticipated that she would file a lawsuit against Edward the following month." Mrs. Smolyansky continued, "On January 23, Julie filed suit. In anticipation of this, on January 3, I began to sell some of my shares to defend Edward. I have no choice, as&nbsp;Lifeway's legal counsel has refused to provide the adequate paperwork to Edward to monetize his holdings in LWAY as permitted under our 1999 Shareholders Agreement between our family member and Group Danone

Reported Earlier, Edward And Ludmila Smolyansky Demand Lifeway Foods CEO Ends Legal Battle

<ul>
<li>Company also announces unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million</li>
<li>Full year 2024 preliminary unaudited net sales are projected to range between $185.0 million and $186.5 million compared to $160.1 million in 2023</li>
</ul>
MORTON GROVE, Ill., Jan. 6, 2025 /PRNewswire/ --&nbsp;Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has responded to the December 30, 2024 letter sent to Lifeway by Danone North America PBC ("Danone") reaffirming that the Company rejected Danone's offer to acquire the Company because it severely undervalues the Company, based on analysis by the Company's independent financial and legal advisors. The Board reiterated that it is not opposed to a sale at a price that more accurately reflects the true value of the Company.

Guidance

Lifeway Foods Responds To Letter From Danone North America PBC Reaffirming Rejection Of Unsolicited Takeover Offer; Also Announces Unaudited Preliminary Q4 Net Sales Between $45.1M-$46.6M; FY24 Preliminary Unaudited Net Sales Are Projected To Range Between $185M-$186.5M Compared To $160.1M In 2023

ifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
The Board determined that Danone's $27.00 per share proposal substantially undervalues the Company. The Board is not, however, opposed to the sale of the Company at any price.
The Board has carefully evaluated the Company's standalone plan&nbsp;and believes it has strong potential to provide superior value to all shareholders as compared to Danone's revised proposal. The Board takes its fiduciary duties seriously and is committed to acting in the best interests of all of the Company's shareholders and other stakeholders.

DANOY

Lifeway Foods Rejects Danone's $27 Per Share Acquisition Proposal, Citing Undervaluation Of The Company

Edward And Ludmila Smolyansky Urge Lifeway Foods To Form Special Committee To Evaluate Danone's $27 Per Share Cash Offer Amid Board's Rejection And Legal Disputes

Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) shares are trading lower on Wednesday after the company&#8217;s Board of Directors rejected a revised unsolicited <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42085549/lifeway-foods-rejects-revised-unsolicited-proposal-from-danone" rel="noreferrer noopener">acquisition proposal from </a><a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42085549/lifeway-foods-rejects-revised-unsolicited-proposal-from-danone" rel="noreferrer noopener">Danone North America PBC</a>.
The proposal on November 15 offered $27.00 per share to acquire all of Lifeway&#8217;s shares that Danone does not already own.
After careful evaluation, including consultations with independent financial and legal advisors, the Lifeway Board determined that the offer significantly undervalued the company and was not in the best interests of Lifeway&#8217;s shareholders or other stakeholders.
According to a recent Schedule 13D amendment filing, Danone beneficially owns approximately&nbsp;23.3%&nbsp;of <a target="_blank" href="https://www.benzinga.com//node/42019636" rel="noreferrer noopener">Lifeway&#8217;s outstanding common stock.</a>
On&nbsp;November 5, 2024, Lifeway announced that its Board had rejected Danone&#8217;s initial unsolicited, non-binding proposal of&nbsp;$25.00&nbsp;per share, citing that it <a target="_blank" href="https://www.benzinga.com//node/41745068" rel="noreferrer noopener">substantially undervalued the company.</a>
Lifeway said it remains committed to its strategic plan of expanding its kefir offerings while also branching into adjacent product categories.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42085436/target-q3-earnings-supply-chain-chaos-hits-bottomline-slashes-annual-profit-outlook-stock-tanks" rel="noreferrer noopener">Target Q3 Earnings: Supply Chain Chaos Hits Bottomline, Slashes Annual Profit Outlook, Stock Tanks</a>
The company reported growth in its third-quarter 2024 results, achieving its 20th consecutive quarter of growth with double-digit year-over-year revenue growth and improved profit margins.
Lifeway said it generated a total shareholder return of 788% over the past five years, vastly outperforming its food and beverage industry peers and the S&amp;P 500.
In line with its growth momentum, Lifeway has also announced the launch of a new functional beverage: Probiotic Smoothie + Collagen <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42089631/lifeway-foods-announces-latest-innovation-probiotic-smoothie-collagen" rel="noreferrer noopener">made with kefir cultures. </a>This product comes in four flavors—Matcha Latte, Berry Blast, Tropical Fruit, and Plain—and contains 5 grams of collagen per serving. It is also lactose-free, capitalizing on the growing consumer demand for lactose-free dairy alternatives.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, LWAY stock has gained over 56% in the past year.
Price Action: LWAY shares are trading lower by 5.72% to $23.89 at last check Wednesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42087908/mutated-bird-flu-case-in-california-puts-humans-at-increased-risk-so-which-companies-are-developing-vaccines" target="_blank" rel="noreferrer noopener">Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?</a></li>
</ul>

Equities

Movers

General

What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?

Lifeway Foods Announced That Its Board Of Directors Has Rejected The Revised Unsolicited Proposal Made On November 15, 2024 By Danone North America To Acquire All The Shares Of Lifeway That It Does Not Already Own For $27.00 Per Share

Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America PBC ("Danone") to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash. According to the Schedule 13D amendment filed today with the U.S. Securities and Exchange Commission disclosing the revised proposal, Danone beneficially owns approximately 23.3% of Lifeway's outstanding common stock.
On November 5, 2024, Lifeway announced that its Board of Directors (the "Board") had rejected Danone's initial unsolicited, non-binding proposal to acquire all the shares of Lifeway that it does not already own for $25.00 per share because the Board determined that the initial proposal substantially undervalued Lifeway and was not in the best interests of the Company and its shareholders and other stakeholders.
Consistent with its fiduciary duties, Lifeway's board of directors, in consultation with its independent outside advisors, will carefully review and evaluate the revised proposal to determine the course of action that it believes is in the best interests of the Company and its shareholders and other stakeholders.
The Company does not undertake any obligation to provide any updates with respect to this or any other proposal or transaction, except as required under applicable law.
Lifeway shareholders do not need to take any action at this time.
Evercore is serving as a financial advisor to Lifeway and Sidley Austin LLP is serving as legal counsel to Lifeway.

Lifeway Foods Confirms Receipt Of Revised, Unsolicited, Non-Binding Proposal From Danone  To Acquire All Outstanding Shares Of Common Stock Of Lifeway It Does Not Already Own For $27.00 Per Share In Cash

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Friday.
Shares of Despegar.com, Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) rose sharply during Friday's session after the company reported <a href="https://www.benzinga.com/quote/DESP/earnings">better-than-expected third-quarter sales.</a>
The company said it sees FY24 revenue of at least $760 million and adjusted EBITDA of at least $170 million
Despegar.com shares jumped 19.1% to $17.70 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) shares jumped 43% to $18.98. Bloom Energy announced a 1 GW fuel cell deal with AEP, providing clean power for AI Data Centers.</li>
<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) gained 22.3% to $4.9200.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) gained 13% to $11.56. The company reported third-quarter results on Thursday.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 12.6% to $23.77.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) jumped 12.5% to $5.50.</li>
<li>Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) gained 11% to $24.85. The company reported quarterly results on Thursday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) rose 10.3% to $5.13. Kingsoft Cloud Holdings will release its unaudited financial results for the third quarter before the open of U.S. markets on Tuesday, Nov. 19.</li>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) gained 7.7% to $44.40.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) shares rose 6.3% to $28.34. The company priced a $200 million public offering of 7,843,137 shares at $25.50 per ADS.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 6% to $62.72 after the company announced it will transfer its stock exchange listing over to the Nasdaq.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) rose 3% to $112.38. The company reported quarterly results on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42007586/top-4-energy-stocks-that-could-blast-off-in-november">Top 4 Energy Stocks That Could Blast Off In November</a></li>
</ul>

CENX

CMPS

DESP

LUNR

PLTR

RCAT

ZLAB

Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday

<a href="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm" title="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm">https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm</a>

Danone North America PBC Sent Second Letter To Lifeway Foods To Express Disappointment In Board's Response To Initial Proposal; Reiterates Danone North America PBC's Strong Commitment To Proposed Transaction; Updated Proposal, Danone North America PBC Increased Offer For Proposed Transaction From $25.00/Share To $27.00/Share

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.27 by 29.63 percent. The company reported quarterly sales of $46.095 million which missed the analyst consensus estimate of $49.750 million by 7.35 percent. This is a 12.71 percent increase over sales of $40.896 million the same period last year.

Earnings Misses

Lifeway Foods Q3 2024 GAAP EPS $0.19 Misses $0.27 Estimate, Sales $46.095M Miss $49.750M Estimate

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Lifeway Foods to report an earnings per share (EPS) of $0.27.
The announcement from Lifeway Foods is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 6.84% increase in the share price on the subsequent day.
Here's a look at Lifeway Foods's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.24</td>
<td>0.21</td>
<td>0.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.25</td>
<td>0.16</td>
<td>0.26</td>
<td>0.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-6.0%</td>
<td>9.0%</td>
<td>39.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731521045_0.png" alt="eps graph" />
<h3>Tracking Lifeway Foods's Stock Performance</h3>
Shares of Lifeway Foods were trading at $24.15 as of November 12. Over the last 52-week period, shares are up 57.14%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Views on Lifeway Foods</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Lifeway Foods.
Lifeway Foods has received a total of 1 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $25.0, the consensus suggests a potential 3.52% upside.
<h3>Peer Ratings Overview</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of and Mama`s Creations, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>For Mama`s Creations, analysts project an Buy trajectory, with an average 1-year price target of $10.0, indicating a potential 58.59% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for and Mama`s Creations, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lifeway Foods</td>
<td>Outperform</td>
<td>25.30%</td>
<td>$13.28M</td>
<td>5.75%</td>
</tr>
<tr>
<td>Mama`s Creations</td>
<td>Buy</td>
<td>14.49%</td>
<td>$6.88M</td>
<td>5.38%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Lifeway Foods ranks higher than its peers in terms of revenue growth and gross profit. However, it has a lower return on equity compared to its peers. Overall, Lifeway Foods is positioned favorably among its peers based on the provided metrics.
<h3>About Lifeway Foods</h3>
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products primarily through direct sales force, brokers, and distributors.
<h3>Key Indicators: Lifeway Foods's Financial Health</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Lifeway Foods's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.3% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Lifeway Foods's net margin is impressive, surpassing industry averages. With a net margin of 7.7%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Lifeway Foods's ROE stands out, surpassing industry averages. With an impressive ROE of 5.75%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Lifeway Foods's ROA stands out, surpassing industry averages. With an impressive ROA of 4.51%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.0, Lifeway Foods adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/LWAY/earnings">To track all earnings releases for Lifeway Foods visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Exploring Lifeway Foods's Earnings Expectations

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Sapiens International Corporation N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SPNS/earnings">third-quarter financial results</a>.
Sapiens Intl posted third-quarter adjusted earnings of 37 cents per share, missing market estimates of 38 cents per share. The company's quarterly sales came in at $137.03 million versus expectations of $140.07 million.
Sapiens International shares dipped 21.5% to $30.98 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Sky Harbour Group Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#NASDAQ">SKYH</a>) shares fell 9% to $10.55 in pre-market trading. Sky Harbour will report its third-quarter financial results on Tuesday, Nov. 12.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) shares dipped 5.7% to $23.05 in pre-market trading after gaining 13% on Friday.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) fell 5.2% to $69.85 in pre-market trading after jumping 30% on Friday.</li>
<li>Xeris Biopharma Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) dipped 4.9% to $3.30 in pre-market trading. Xeris Biopharma Holdings posted upbeat quarterly results on Friday.</li>
<li>Gold Fields Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) declined 4.7% to $15.06 in pre-market trading.</li>
<li>Lifeway Foods, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) declined 4.2% to $22.10 in pre-market trading after falling 8% on Friday.</li>
<li>Butterfly Network, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) fell 3.4% to $2.53 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone">Dow, S&amp;P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

BFLY

SKYH

SPNS

XERS

Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Revelation Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/REVB/earnings">third-quarter EPS results</a>.
Revelation Biosciences a reported quarterly loss of 84 cents per share compared to market estimates of a loss of $2.84 per share.
Revelation Biosciences shares surged 48.8% to $1.22 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>New Horizon Aircraft Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) gained 68.2% to $0.4879 in pre-market trading.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) rose 61.1% to $0.2980 in pre-market trading after gaining around 10% on Friday.</li>
<li>Destiny Tech100 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NASDAQ">DXYZ</a>) gained 27.1% to $46.01 in pre-market trading after jumping 64% on Friday.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares rose 18.8% to $0.3791 in pre-market trading.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) climbed 17.4% to $0.5824 in pre-market trading after jumping around 35% on Friday.</li>
<li>Autolus Therapeutics plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) gained 17.1% to $4.37 in pre-market trading after the company reported the FDA approval of AUCATZYL&#xAE; (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-A.</li>
<li>Prestige Wealth Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) gained 16.5% to $0.98 in pre-market trading. Prestige Wealth announced the acquisitions of InnoSphere Tech and closing of acquisition of Wealth AI.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) rose 16% to $314.06 in pre-market trading amid strength in Bitcoin.</li>
<li>MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) gained 15.3% to $22.25 in pre-market trading amid strength in Bitcoin.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares tumbled 29.7% to $2.98 in pre-market trading.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares fell 13% to $0.0374 in pre-market trading. Jet.AI shares dipped 25% on Friday after the company announced a 1-for-225 reverse stock split.</li>
<li>Heramba Electric plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) shares fell 12.3% to $1.07 in pre-market trading.</li>
<li>Li-Cycle Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NASDAQ">LICY</a>) declined 12.1% to $2.9000 in pre-market trading. Li-Cycle shares fell around 9% on Friday after the company reported third-quarter financial results.</li>
<li>Fresh2 Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRES#NASDAQ">FRES</a>) dipped 11.8% to $1.1200 in pre-market trading.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) fell 9.7% to $0.0980 in pre-market trading after surging over 13% on Friday.</li>
<li>FutureFuel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) shares dipped 9.5% to $5.51 in pre-market trading after the company posted a loss for the third quarter.</li>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) fell 9% to $0.9100 in today's pre-market trading after surging around 14% on Friday.</li>
<li>Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) fell 8.8% to $21.01 in pre-market trading. Lifeway Foods will report financial results for the third quarter ended Sept. 30, 2024 on Nov. 14, before the opening bell.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) fell 7.1% to $68.50 in pre-market trading after jumping 30% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone">Dow, S&amp;P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

AUTL

COIN

DWTX

DXYZ

FOXO

FRES

HOVR

JTAI

LICY

MARA

PITA

REVB

SPPL

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has rejected the unsolicited proposal made on September 23, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $25.00 per share.
After careful and thorough consideration, conducted in consultation with its independent financial and legal advisors, the Board determined that Danone's opportunistic proposal substantially undervalues Lifeway and is not in the best interests of the Company and its shareholders or other stakeholders. In addition, in response to Danone's proposal and its substantial ownership position in the Company, the Board adopted a limited duration shareholder rights plan, effective immediately (the "Rights Plan").

Management

Lifeway Foods Rejects Proposal To Acquire All The Shares Of Lifeway That It Does Not Already Own For $25.00 Per Share From Danone; Adopts Limited Duration Shareholder Rights Plan

According to the Schedule 13D amendment filed yesterday with the U.S. Securities and Exchange Commission disclosing the proposal,&nbsp;Danone beneficially owns approximately&nbsp;23.4%&nbsp;of Lifeway&#39;s outstanding common stock.
Lifeway shareholders do not need to take any action at this time.&nbsp;

Lifeway Foods Confirms Receipt Of $25.00 Per Share Cash, Non-binding Proposal From Danone North America

Press Releases

LIFEWAY FOODS EXPECTS TO REALIZE $5 MILLION NET GAIN FROM SALE OF SIMPLE FOODS TO FLOWERS FOODS

/C O R R E C T I O N -- Lifeway Foods, Inc./

Lifeway Farmer Cheese Expanding Footprint and Entering 1,400 Albertsons Stores Across the U.S.

Lifeway Foods® to Showcase New Probiotic Salad Dressing Innovations and Conventional Whole Milk Kefir Expansion at Natural Products Expo West 2025

Lifeway Foods® CEO Julie Smolyansky to Appear with Katie Couric at the SHE Media Co-Lab at SXSW® to Discuss Gut Health Trends and History of Lifeway Kefir

LIFEWAY FOODS STATEMENT REGARDING DANONE'S LATEST ACTIONS, CONTINUING DANONE'S HISTORY AS A TOXIC BUSINESS PARTNER

Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

Edward Smolyansky Launches Campaign to Replace Board of Directors at Lifeway Foods (NASDAQ: LWAY)

After Reporting Record Full Year 2024 Earnings and 22nd Consecutive Quarter of Growth, Lifeway Foods Issues Statement on Edward Smolyansky's Director Nomination Notice

Comments

Lifeway Foods

Lifeway Foods (LWAY) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル